← Back to Search

Virtual Reality Goggles for Cancer

N/A
Waitlist Available
Led By Ryan J Li
Research Sponsored by OHSU Knight Cancer Institute
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up immediately after chemotherapy infusion is complete
Awards & highlights

Study Summary

This trial looks at using VR goggles to reduce anxiety during chemotherapy for patients with head/neck, thoracic, and breast cancer. VR can provide interactive games, relaxing experiences and immersive videos to help manage anxiety.

Eligible Conditions
  • Blood Cancers
  • Cancer
  • Lung Cancer
  • Breast Cancer
  • Head and Neck Cancers

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~before the start of chemotherapy infusion and 30-minutes of virtual reality (vr)/smartphone use is completed
This trial's timeline: 3 weeks for screening, Varies for treatment, and before the start of chemotherapy infusion and 30-minutes of virtual reality (vr)/smartphone use is completed for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Difference in anxiety levels
Secondary outcome measures
Participants' satisfaction with the VR device
Short-term difference in anxiety levels

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Group 1 (VR)Experimental Treatment2 Interventions
Patients use VR during chemotherapy infusion on study.
Group II: Group 2 (Smartphone)Active Control2 Interventions
Patients use smartphone during chemotherapy infusion on study.

Find a Location

Who is running the clinical trial?

OHSU Knight Cancer InstituteLead Sponsor
230 Previous Clinical Trials
2,090,676 Total Patients Enrolled
Oregon Health and Science UniversityOTHER
973 Previous Clinical Trials
6,845,979 Total Patients Enrolled
Ryan J LiPrincipal InvestigatorOHSU Knight Cancer Institute
3 Previous Clinical Trials
152 Total Patients Enrolled

Media Library

Group 1 (VR) Clinical Trial Eligibility Overview. Trial Name: NCT05793957 — N/A
Blood Cancers Research Study Groups: Group 1 (VR), Group 2 (Smartphone)
Blood Cancers Clinical Trial 2023: Group 1 (VR) Highlights & Side Effects. Trial Name: NCT05793957 — N/A
Group 1 (VR) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05793957 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

For which individuals is this clinical trial an appropriate option?

"Patients aged 18 - 89 who have been diagnosed with breast cancer can apply for this trial that is enrolling a total of 44 participants."

Answered by AI

Is this research project recruiting participants?

"As evidenced by clinicaltrials.gov, this scientific research is no longer actively recruiting participants as it was last updated on March 30th 2023. Despite its conclusion, there are nearly 5000 other medical trials seeking individuals to participate in them currently."

Answered by AI

Does the research protocol include any participants of advanced age?

"According to the eligibility criteria for this medical trial, applicants must fall within the age range of 18-89. Additionally, there is a total of 380 trials available exclusively for those under 18 and 4720 specifically designed for seniors over 65."

Answered by AI
~25 spots leftby Apr 2025